CDH1 and cancer: Epithelial-mesenchymal transition (EMT), a process by which cancer cells lose their epithelial properties and acquire mesenchymal phenotypes such as motility and invasiveness [31–33], is activated synergistically by a number of factors including Slug, Snail, E-cadherin, Twist, and vimentin [34–39].